Linzela Capsule

Introduction

Linzela Capsule 72 mcg is a medication used to treat certain gastrointestinal conditions, particularly irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). It is a guanylate cyclase-C agonist that works to improve bowel function and relieve symptoms associated with constipation.

Uses

Linzela Capsule 72 mcg is prescribed for:

Chronic Idiopathic Constipation (CIC): Provides relief from constipation that is not caused by another condition.
Irritable Bowel Syndrome with Constipation (IBS-C): Alleviates symptoms of constipation and abdominal discomfort associated with IBS.

Brand Name	Linzela
Type	Capsule
Weight	72 mcg
Generic	Linaclotide
Manufacturer	Nuvista Pharma Ltd.
Available in	English বাংলা

Mechanism of Action

Linzela Capsule 72 mcg works by binding to and activating guanylate cyclase-C receptors on the intestinal epithelium. This activation leads to an increase in intracellular cyclic guanosine monophosphate (cGMP), which subsequently enhances chloride and bicarbonate secretion into the intestinal lumen. This process increases intestinal fluid secretion, improves bowel movements, and reduces pain associated with constipation.

How Long Does It Take to Work?

Linzela Capsule 72 mcg typically begins to work within 1 to 2 weeks of starting treatment. The onset of relief from symptoms such as constipation and abdominal pain may vary among individuals, with some experiencing improvements sooner than others.

Absorption

Linzela Capsule 72 mcg is administered orally and is minimally absorbed systemically. The drug remains largely in the gastrointestinal tract, where it exerts its therapeutic effects. This limited systemic absorption helps to minimize potential systemic side effects.

Route of Elimination

Linzela Capsule 72 mcg is primarily eliminated through the feces. It is metabolized locally in the gastrointestinal tract, with very little drug being absorbed into the bloodstream. The drug and its metabolites are excreted in the stool.

Dosage

Irritable Bowel Syndrome with Constipation (IBS-C): The recommended dosage of Linaclotide is 290 mcg capsule orally once daily.

Chronic Idiopathic Constipation (CIC): The recommended dosage of Linaclotide is 145 mcg capsules orally once daily. A dosage of 72 mcg capsule once daily may be used based on individual presentation or tolerability.

The typical dosage of linaclotide is 290 micrograms once daily for adults with chronic idiopathic constipation or irritable bowel syndrome with constipation. Dosage adjustments are generally not recommended, and the medication should be taken as prescribed.

Administration

Linzela Capsule 72 mcg is administered orally in the form of a capsule. It should be taken on an empty stomach, at least 30 minutes before the first meal of the day. The capsule should be swallowed whole with water and should not be chewed or crushed.

Side Effects

Common side effects of linaclotide include:

Diarrhea.
Abdominal pain.
Bloating.
Flatulence.

Serious side effects may include:

Severe dehydration.
Electrolyte imbalances (e.g., low potassium).

Toxicity

Toxicity from linaclotide is rare but may occur in cases of overdose. Symptoms of overdose may include severe diarrhea and dehydration. Treatment involves supportive care, including rehydration and electrolyte management.

Precautions

Precautions include:

Monitoring for signs of dehydration or electrolyte imbalances, especially in patients with underlying conditions.
Discontinuing use if severe diarrhea occurs.
Using with caution in patients with a history of gastrointestinal obstruction or inflammatory bowel disease.

Interaction

Linzela Capsule 72 mcg may interact with other medications that affect gastrointestinal motility or fluid balance. It is important to inform healthcare providers of all other medications being taken to avoid potential interactions.

Disease Interaction

Use linaclotide with caution in patients with:

Severe dehydration or electrolyte imbalances.
Inflammatory bowel disease (e.g., Crohn's disease or ulcerative colitis).
Gastrointestinal obstruction.

Drug Interaction

Linzela Capsule 72 mcg does not have significant interactions with most drugs. However, it is advisable to review all medications with a healthcare provider to ensure that no interactions affect the efficacy or safety of linaclotide treatment.

Food Interactions

Linzela Capsule 72 mcg should be taken on an empty stomach. Food and drink do not significantly affect its absorption or efficacy, but taking it with food may reduce its effectiveness and lead to increased side effects.

Pregnancy Use

Linzela Capsule 72 mcg is classified as a Category C drug by the FDA, indicating that risk to the fetus cannot be ruled out. It should be used during pregnancy only if the potential benefits justify the risks. Pregnant women should consult their healthcare provider before starting treatment.

Lactation Use

It is not known whether linaclotide is excreted in breast milk. Caution is advised when using linaclotide during breastfeeding, and a healthcare provider should be consulted to weigh the potential benefits and risks.

Acute Overdose

Acute overdose of linaclotide can cause severe diarrhea and dehydration. In case of overdose, discontinue the medication and provide supportive care, including rehydration and monitoring of electrolyte levels.

Contraindication

Linzela Capsule 72 mcg is contraindicated in patients with:

Known or suspected gastrointestinal obstruction.
Severe dehydration or electrolyte imbalance.

Use Direction

Linzela Capsule 72 mcg should be taken once daily, ideally on an empty stomach before the first meal of the day. The capsule should be swallowed whole with water, without chewing or crushing.

Storage Conditions

Linzela Capsule 72 mcg should be stored at room temperature, between 20°C to 25°C (68°F to 77°F). Keep the medication in its original container, tightly closed, and away from moisture and light. Keep out of reach of children.

Volume of Distribution

The volume of distribution for linaclotide is not well-documented due to its minimal systemic absorption. The drug primarily acts locally within the gastrointestinal tract.

Half Life

Linzela Capsule 72 mcg has a relatively short half-life of approximately 1.5 hours. Despite this, its effects persist due to its action within the gastrointestinal lumen.

Clearance

Linzela Capsule 72 mcg is primarily cleared through the feces. Systemic clearance is minimal due to limited absorption, with most of the drug being metabolized locally in the gastrointestinal tract.

See in details version Linzela Capsule 72 mcg also Linzela Capsule 72 mcg in bangla